Benzinga | Sep 20, 2021 07:49AM EDT

Truist Securities Maintains Buy on Exelixis, Lowers Price Target to $36

Truist Securities analyst Asthika Goonewardene maintains Exelixis (NASDAQ:EXEL) with a Buy and lowers the price target from $37 to $36.